Product Center

Campylobacter Antimicrobic Supplement, Blaser , 5 mL



Cat. # Description Qty. Unit
214890 Campylobacter Antimicrobic Supplement, Blaser , 5 mL
(Vancomycin, Polymyxin B, Trimethoprim, Cephalothin, Amphotericin B) Each vial when reconstituted to prepare 500 mL of Campylobacter Agar, Blaser formulation.
6 SP

Intended Use:

Difco™ Campylobacter Agar Base, when supplemented with blood and antimicrobial agents, is used for the primary isolation and cultivation of Campylobacter jejuni subsp. jejuni from human fecal specimens. Difco Camplylobacter Antimicrobic Supplement Skirrow and Difco Campylobacter Antimicrobic Supplement Blaser are used for preparing Campylobacter Agar according to the formulations of Skirrow1 and Blaser et al.2,3


Catalog # Description Brand Quantity Unit
214890 Campylobacter Antimicrobic Supplement, Blaser , 5 mL
(Vancomycin, Polymyxin B, Trimethoprim, Cephalothin, Amphotericin B) Each vial when reconstituted to prepare 500 mL of Campylobacter Agar, Blaser formulation.
Difco 6 SP

Difco™ Campylobacter Antimicrobic Supplement Skirrow · Difco™ Campylobacter Antimicrobic Supplement Blaser
Revision: 0103     Revision Date: 01/01/2003    

Intended Use:

Difco™ Campylobacter Agar Base, when supplemented with blood and antimicrobial agents, is used for the primary isolation and cultivation of Campylobacter jejuni subsp. jejuni from human fecal specimens. Difco Camplylobacter Antimicrobic Supplement Skirrow and Difco Campylobacter Antimicrobic Supplement Blaser are used for preparing Campylobacter Agar according to the formulations of Skirrow1 and Blaser et al.2,3



Product Summary:

In 1972, Dekeyser et al. reported that C. jejuni was isolated from the feces of patients with diarrhea and acute gastroenteritis using a filtration technique and a blood-containing selective medium with antimicrobics to suppress the normal enteric flora.4 Subsequently, Skirrow and other investigators reported similar blood-based selective media that differed in the numbers and types of antimicrobics.1-3,5,6

In 1978, Blaser et al. reported success in isolating C. jejuni with a medium containing four antimicrobics incorporated into Brucella Agar supplemented with 10% defibrinated sheep blood.2,3 Subsequently, cephalothin was incorporated to increase its ability to inhibit the normal bacterial flora associated with fecal specimens.5



User Quality Control:

1. Examine the agar base for color and texture. The powder should be beige, free-flowing and homogeneous.

2. Determine the pH of the medium after preparation and cooling to 25°C. The pH should be 7.4 ± 0.2.

3. Examine the lyophilized and rehydrated antimicrobic supplement for evidence of deterioration as described under "Product Deterioration."

4. Check the performance of the base and antimicrobic supplement by testing in the complete medium. Plates should be inoculated with approximately 100-1,000 colony forming units (CFUs) of the test cultures and incubated at 42°C in a reduced oxygen atmosphere. Examine plates for growth after 24 and 48 h incubation.


Organism

ATCC™
Recovery
Skirrow
Recovery
Blaser
Campylobacter jejuni
subsp. jejuni

Campylobacter jejuni
subsp. jejuni

Candida albicans

Enterococcus faecalis

Escherichia coli
29428


33291


10231

33186

25922
Good


Good


Good

Inhibited

Inhibited
Good


Good


Inhibited

Inhibited

Inhibited


Reagents:

Difco Campylobacter Antimicrobic Supplement Skirrow
  Formula Per 5 mL Vial
  Vancomycin  5.0   mg
  Polymyxin B  1250.0   units
  Trimethoprim  2.5   mg
 
DifcoCampylobacter Antimicrobic Supplement Blaser
  Formula Per 5 mL Vial
  Vancomycin  5.0   mg
  Polymyxin B  1250.0   units
  Trimethoprim  2.5   mg
  Cephalothin  7.5   mg
  Amphotericin B  1.0   mg


Warnings and Precautions:

For Laboratory Use

Use aseptic technique in rehydrating the supplements and in adding the supplements to the basal medium.

Follow proper, established laboratory procedures in handling and disposing of infectious materials.



Information shown on this page is a short summary extracted from the Package Insert, available as a PDF under the Related Documents section of this page.